Nucleic Acid Amplification Detection and Diagnostics Market projected to reach US$ 38,162.68 million by 2027 Says, The Insight Partners
According to The Insight Partners market research study of “Nucleic Acid Amplification, Detection, and Diagnostics Market Forecast to 2027 – COVID-19 Impact and Global Analysis – by Nucleic Acid, Process, Product Type, Technology, Application, End User, and Geography”, the global nucleic acid amplification, detection, and diagnostics market is expected to reach US$ 38,162.68 million by 2027 from US$ 14,014.59 million in 2019. The market is estimated to grow at a CAGR of 13.4% from 2020 to 2027. The report highlights trends prevailing in the global nucleic acid amplification, detection, and diagnostics market and the factors driving market along with those that act as hindrances.
Nucleic acid amplification technologies are used for the rapid and accurate diagnosis of chronic and infectious diseases. The nucleic acid amplification is one of the important tool for wide aspects of life science technologies including, clinical medicine development, diagnosis of infectious diseases, and gene cloning. Extensively increasing prevalence of chronic as well as infectious diseases is boosting the demand for state-of-the-art diagnostic systems. The nucleic acid amplification, detection, and diagnostics market is expected to witness a significant growth due to increasing prevalence of infectious diseases and rising demand for advanced diagnostic systems. However, lack of adequate infrastructure in emerging countries is estimated to hamper the growth of the market during the forecast period.
Nucleic Acid Amplification Detection and Diagnostics Market: Competition Landscape and Key Developments
BD, bioMerieux SA, Bio-Rad Laboratories Inc., Thermo Fisher Scientific Inc., Illumina, Inc., Danaher, QIAGEN, Abbott, Meridian Bioscience, Inc., and F. Hoffmann-La Roche Ltd. are among the leading companies operating in the nucleic acid amplification, detection, and diagnostics market.
Request for sample Pages of Nucleic Acid Amplification Detection and Diagnostics Market Study at: https://www.theinsightpartners.com/sample/TIPRE00016305/
Increasing Demand for Accurate and Modern Diagnostic Measures
The nucleic acid amplification is one of the important tools used among life science technologies such as clinical medicine development, diagnosis of infectious diseases, and gene cloning. Increasing prevalence of chronic as well as infectious diseases is boosting the demand for state-of-the-art diagnostic systems. Continuous R&D activities, significant investments, and focus on development of reagents and kits formulations for nucleic acid amplification technologies hold substantial potential to provide rapid and reliable diagnosis compared to other IVD (In-Vitro Diagnostics) tests. Moreover, various players have developed integrated, portable, and micro-fluidics based platforms with an aim to increase the functionality of diagnostic analysis and sensing. bioMerieux’s NucliSENS easyQ tests and Enigma Diagnostics’s MiniLab are some of the systems that offer microfluidics-based platforms, which are cost-effective and user-friendly.
Increasing number of investments and collaborations are playing a vital role in the development of advanced diagnostic kits and instruments. Additionally, the pharmaceutical companies and research institutes are emphasizing on utilizing nucleic acid amplification technologies, as they offer superior precession in disease diagnosis. For instance, in June 2020, Shionogi & Co., Ltd., a significant player in Japan pharmaceutical market entered into strategic collaboration with Gunma University, Nihon University, and Tokyo Medical University for the development of modernized diagnostic system for the detection of infectious diseases. This collaboration will exclusively work on signal amplification method in order to develop rapid test product.
Nucleic Acid Amplification Detection and Diagnostics Market: Segmental Overview
Based on process, the nucleic acid amplification, detection, and diagnostics market is segmented into diagnostics, amplification, and detection. The amplification segment is further sub-segmented as transcription-mediated amplification (TMA), loop-mediated isothermal amplification (LMIA), strand displacement amplification (SDA), helicase-dependent amplification (HDA), nucleic acid sequence-based amplification (NASBA), and others. The diagnostics segment held the largest share of the market in 2019 and is estimated to register the fastest growth during the forecast period.
Based on technology, the nucleic acid amplification, detection, and diagnostics market is segmented into polymerase chain reaction (PCR), next generation sequencing (NGS), isothermal amplification technology, direct nucleic acid detection, and CRISPR-Cas9. The polymerase chain reaction (PCR) segment is further sub-segmented as Quantitative PCR (qPCR), reverse-transcriptase (RT–PCR), multiplex PCR, nested PCR, in-situ PCR, and others. In addition, isothermal amplification technology segment is sub-segmented as target amplification systems, probe amplification systems, and signal amplification systems. Direct nucleic acid detection segment is further sub-segmented as aptamers, DNA biosensors, and others. The polymerase chain reaction (PCR) segment held the largest share of the market in 2019 and is estimated to register the fastest growth during the forecast period.
Inquiry for Discount at: https://www.theinsightpartners.com/discount/TIPRE00016305/
The emergence of coronavirus is expected to have positive impact on the market growth. As nucleic acid related diagnostic technologies offer superior outcomes, majority of the market players are focusing on the product development equipped with nucleic acid tests. However, implementation of physical distancing policies and total shut down of businesses in order to prevent the viral infection disrupted the supply chain operations, which deterred the market growth by certain extent.
Nucleic Acid Amplification Detection and Diagnostics Market– By Geography
- North America
- Rest of Europe
- Asia Pacific (APAC)
- South Korea
- Rest of APAC
- Middle East & Africa (MEA)
- South Africa
- Saudi Arabia
- Rest of MEA
- South & Central America (SCAM)
- Rest of SCAM
Nucleic Acid Amplification Detection and Diagnostics Market Research Study at: https://www.theinsightpartners.com/buy/TIPRE00016305/
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials.
If you have any queries about this report or if you would like further information, please contact us: